Douglas Tsao
Stock Analyst at H.C. Wainwright
(4.86)
# 354
Out of 4,429 analysts
1215
Total ratings
53.6%
Success rate
19.5%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Reiterated: Hold | $43 | $44.99 | -4.42% | 57 | Jun 18, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $18 → $7 | $1.51 | +363.58% | 23 | Jun 16, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $5 | $5.02 | -0.40% | 45 | Jun 15, 2026 | |
| CRNX Crinetics Pharmaceuticals | Reiterated: Buy | $81 | $35.87 | +125.82% | 63 | Jun 15, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | n/a | $2.84 | - | 50 | Jun 8, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | n/a | $70.79 | - | 37 | Jun 8, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $1,201 | $282.31 | +325.42% | 55 | Jun 8, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $940 | $877.72 | +7.10% | 64 | Jun 4, 2026 | |
| BHVN Biohaven | Reiterated: Hold | $10 | $13.57 | -26.31% | 21 | Jun 1, 2026 | |
| STO: HNSA Hansa Biopharma AB (publ) | Reiterated: Buy | kr 103.00 | $32.22 | +219.68% | 50 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $35.34 | +13.19% | 45 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $31.43 | +8.18% | 45 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.17 | +453.00% | 40 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.48 | +372.97% | 77 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.47 | +56.60% | 43 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $112.86 | +3.67% | 78 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $26.21 | +29.72% | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $52.91 | +39.86% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $16.63 | +32.29% | 29 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.63 | +96.08% | 56 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $22.33 | +70.17% | 28 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.5 | $1.58 | -68.35% | 47 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $37.34 | +7.12% | 10 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $15 | $16.58 | -9.53% | 39 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.56 | +173.44% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $5 | $0.0111 | n/a | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 | $0.668 | n/a | 9 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.000001 | n/a | 13 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $11.45 | n/a | 4 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.95 | n/a | 19 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €19.00 → €11.00 | $4.13 | n/a | 7 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $31.48 | n/a | 12 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $31 → $33 | $31.85 | n/a | 2 | Jul 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $93 → $80 | $10.25 | n/a | 8 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $6.57 | n/a | 17 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $16.21 | n/a | 2 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $71 → $77 | $78.71 | n/a | 6 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 → $120 | $146.00 | n/a | 12 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $167.77 | n/a | 3 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $68.55 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $47 → $50 | $15.37 | n/a | 6 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $224.66 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $185.00 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 → $2 | $7.53 | n/a | 5 | Nov 16, 2016 |
Alkermes
Jun 18, 2026
Reiterated: Hold
Price Target: $43
Current: $44.99
Upside: -4.42%
Neumora Therapeutics
Jun 16, 2026
Reiterated: Buy
Price Target: $18 → $7
Current: $1.51
Upside: +363.58%
Rezolute
Jun 15, 2026
Reiterated: Buy
Price Target: $5
Current: $5.02
Upside: -0.40%
Crinetics Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: $81
Current: $35.87
Upside: +125.82%
Cabaletta Bio
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.84
Upside: -
Disc Medicine
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $70.79
Upside: -
Praxis Precision Medicines
Jun 8, 2026
Maintained: Buy
Price Target: $1,201
Current: $282.31
Upside: +325.42%
argenx SE
Jun 4, 2026
Reiterated: Buy
Price Target: $940
Current: $877.72
Upside: +7.10%
Biohaven
Jun 1, 2026
Reiterated: Hold
Price Target: $10
Current: $13.57
Upside: -26.31%
Hansa Biopharma AB (publ)
May 26, 2026
Reiterated: Buy
Price Target: kr 103.00
Current: $32.22
Upside: +219.68%
May 26, 2026
Reiterated: Buy
Price Target: $40
Current: $35.34
Upside: +13.19%
May 21, 2026
Reiterated: Buy
Price Target: $34
Current: $31.43
Upside: +8.18%
May 15, 2026
Reiterated: Buy
Price Target: $12
Current: $2.17
Upside: +453.00%
May 12, 2026
Reiterated: Buy
Price Target: $7
Current: $1.48
Upside: +372.97%
May 11, 2026
Reiterated: Hold
Price Target: $7
Current: $4.47
Upside: +56.60%
May 11, 2026
Reiterated: Buy
Price Target: $117
Current: $112.86
Upside: +3.67%
May 11, 2026
Reiterated: Buy
Price Target: $34
Current: $26.21
Upside: +29.72%
May 8, 2026
Reiterated: Buy
Price Target: $74
Current: $52.91
Upside: +39.86%
May 6, 2026
Reiterated: Buy
Price Target: $22
Current: $16.63
Upside: +32.29%
May 5, 2026
Maintained: Buy
Price Target: $13
Current: $6.63
Upside: +96.08%
May 4, 2026
Reiterated: Buy
Price Target: $38
Current: $22.33
Upside: +70.17%
Apr 8, 2026
Reiterated: Hold
Price Target: $0.5
Current: $1.58
Upside: -68.35%
Mar 11, 2026
Reiterated: Buy
Price Target: $40
Current: $37.34
Upside: +7.12%
Mar 4, 2026
Rated: Buy
Price Target: $20 → $15
Current: $16.58
Upside: -9.53%
Nov 6, 2025
Reiterated: Buy
Price Target: $7
Current: $2.56
Upside: +173.44%
Nov 14, 2024
Downgraded: Hold
Price Target: $125 → $5
Current: $0.0111
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $360
Current: $0.668
Upside: n/a
Aug 21, 2023
Reiterated: Buy
Price Target: $4 → $3
Current: $0.000001
Upside: n/a
Mar 8, 2023
Maintained: Hold
Price Target: $6
Current: $11.45
Upside: n/a
Nov 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.95
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: €19.00 → €11.00
Current: $4.13
Upside: n/a
Aug 6, 2018
Maintained: Hold
Price Target: $23
Current: $31.48
Upside: n/a
Jul 3, 2018
Maintained: Sell
Price Target: $31 → $33
Current: $31.85
Upside: n/a
Jun 6, 2018
Downgraded: Hold
Price Target: $93 → $80
Current: $10.25
Upside: n/a
Jun 6, 2018
Upgraded: Buy
Price Target: n/a
Current: $6.57
Upside: n/a
May 1, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $16.21
Upside: n/a
Feb 16, 2018
Maintained: Hold
Price Target: $71 → $77
Current: $78.71
Upside: n/a
Oct 27, 2017
Maintained: Hold
Price Target: $108 → $120
Current: $146.00
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $100 → $120
Current: $167.77
Upside: n/a
Jun 22, 2017
Maintained: Buy
Price Target: $16
Current: $68.55
Upside: n/a
May 22, 2017
Upgraded: Buy
Price Target: $47 → $50
Current: $15.37
Upside: n/a
Jan 18, 2017
Maintained: Buy
Price Target: $200
Current: $224.66
Upside: n/a
Nov 30, 2016
Upgraded: Hold
Price Target: n/a
Current: $185.00
Upside: n/a
Nov 16, 2016
Reiterated: Sell
Price Target: $14 → $2
Current: $7.53
Upside: n/a